nodes	percent_of_prediction	percent_of_DWPC	metapath
Clobazam—SLC6A1—amyotrophic lateral sclerosis	0.784	1	CbGaD
Clobazam—Stiffness—Riluzole—amyotrophic lateral sclerosis	0.00526	0.0584	CcSEcCtD
Clobazam—SLC6A1—hindbrain—amyotrophic lateral sclerosis	0.00466	0.102	CbGeAlD
Clobazam—Hostility—Riluzole—amyotrophic lateral sclerosis	0.00361	0.0401	CcSEcCtD
Clobazam—SLC6A11—spinal cord—amyotrophic lateral sclerosis	0.00355	0.0778	CbGeAlD
Clobazam—SLC6A11—nervous system—amyotrophic lateral sclerosis	0.00299	0.0655	CbGeAlD
Clobazam—SLC6A11—central nervous system—amyotrophic lateral sclerosis	0.00288	0.0631	CbGeAlD
Clobazam—Delusion—Riluzole—amyotrophic lateral sclerosis	0.00283	0.0313	CcSEcCtD
Clobazam—Apathy—Riluzole—amyotrophic lateral sclerosis	0.0028	0.0311	CcSEcCtD
Clobazam—Flat affect—Riluzole—amyotrophic lateral sclerosis	0.00278	0.0308	CcSEcCtD
Clobazam—SLC6A1—brainstem—amyotrophic lateral sclerosis	0.00267	0.0585	CbGeAlD
Clobazam—Pulmonary function test decreased—Riluzole—amyotrophic lateral sclerosis	0.00266	0.0295	CcSEcCtD
Clobazam—Respiratory depression—Riluzole—amyotrophic lateral sclerosis	0.00266	0.0295	CcSEcCtD
Clobazam—Delirium—Riluzole—amyotrophic lateral sclerosis	0.00233	0.0258	CcSEcCtD
Clobazam—SLC6A11—brain—amyotrophic lateral sclerosis	0.00229	0.0501	CbGeAlD
Clobazam—Musculoskeletal stiffness—Riluzole—amyotrophic lateral sclerosis	0.00223	0.0247	CcSEcCtD
Clobazam—Dysarthria—Riluzole—amyotrophic lateral sclerosis	0.00212	0.0235	CcSEcCtD
Clobazam—Respiratory failure—Riluzole—amyotrophic lateral sclerosis	0.00204	0.0226	CcSEcCtD
Clobazam—SLC6A1—medulla oblongata—amyotrophic lateral sclerosis	0.00186	0.0408	CbGeAlD
Clobazam—GABRB2—hindbrain—amyotrophic lateral sclerosis	0.00186	0.0407	CbGeAlD
Clobazam—Euphoric mood—Riluzole—amyotrophic lateral sclerosis	0.00172	0.0191	CcSEcCtD
Clobazam—SLC6A1—spinal cord—amyotrophic lateral sclerosis	0.00166	0.0364	CbGeAlD
Clobazam—GABRA1—hindbrain—amyotrophic lateral sclerosis	0.00164	0.0359	CbGeAlD
Clobazam—Libido decreased—Riluzole—amyotrophic lateral sclerosis	0.00157	0.0174	CcSEcCtD
Clobazam—Amnesia—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0171	CcSEcCtD
Clobazam—Increased appetite—Riluzole—amyotrophic lateral sclerosis	0.00155	0.0171	CcSEcCtD
Clobazam—Osteoarthritis—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0161	CcSEcCtD
Clobazam—Diplopia—Riluzole—amyotrophic lateral sclerosis	0.00145	0.0161	CcSEcCtD
Clobazam—Disturbance in sexual arousal—Riluzole—amyotrophic lateral sclerosis	0.00144	0.016	CcSEcCtD
Clobazam—Psychotic disorder—Riluzole—amyotrophic lateral sclerosis	0.00142	0.0157	CcSEcCtD
Clobazam—SLC6A1—nervous system—amyotrophic lateral sclerosis	0.0014	0.0307	CbGeAlD
Clobazam—Ataxia—Riluzole—amyotrophic lateral sclerosis	0.00137	0.0151	CcSEcCtD
Clobazam—SLC6A1—central nervous system—amyotrophic lateral sclerosis	0.00135	0.0295	CbGeAlD
Clobazam—Liver function test abnormal—Riluzole—amyotrophic lateral sclerosis	0.00134	0.0149	CcSEcCtD
Clobazam—SLC6A1—cerebellum—amyotrophic lateral sclerosis	0.00132	0.0289	CbGeAlD
Clobazam—Muscular weakness—Riluzole—amyotrophic lateral sclerosis	0.00128	0.0142	CcSEcCtD
Clobazam—Abdominal distension—Riluzole—amyotrophic lateral sclerosis	0.00126	0.014	CcSEcCtD
Clobazam—Asthma—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0139	CcSEcCtD
Clobazam—Dysphagia—Riluzole—amyotrophic lateral sclerosis	0.00126	0.0139	CcSEcCtD
Clobazam—Bronchitis—Riluzole—amyotrophic lateral sclerosis	0.00121	0.0134	CcSEcCtD
Clobazam—Weight increased—Riluzole—amyotrophic lateral sclerosis	0.00114	0.0127	CcSEcCtD
Clobazam—Pneumonia—Riluzole—amyotrophic lateral sclerosis	0.00113	0.0125	CcSEcCtD
Clobazam—Infestation—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0124	CcSEcCtD
Clobazam—Infestation NOS—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0124	CcSEcCtD
Clobazam—Depression—Riluzole—amyotrophic lateral sclerosis	0.00112	0.0124	CcSEcCtD
Clobazam—Urinary tract infection—Riluzole—amyotrophic lateral sclerosis	0.00109	0.0121	CcSEcCtD
Clobazam—Sweating—Riluzole—amyotrophic lateral sclerosis	0.00107	0.0119	CcSEcCtD
Clobazam—SLC6A1—brain—amyotrophic lateral sclerosis	0.00107	0.0234	CbGeAlD
Clobazam—GABRB2—brainstem—amyotrophic lateral sclerosis	0.00106	0.0233	CbGeAlD
Clobazam—Hallucination—Riluzole—amyotrophic lateral sclerosis	0.001	0.0111	CcSEcCtD
Clobazam—Erythema multiforme—Riluzole—amyotrophic lateral sclerosis	0.00095	0.0105	CcSEcCtD
Clobazam—GABRA1—brainstem—amyotrophic lateral sclerosis	0.00094	0.0206	CbGeAlD
Clobazam—Eye disorder—Riluzole—amyotrophic lateral sclerosis	0.000939	0.0104	CcSEcCtD
Clobazam—Mental disorder—Riluzole—amyotrophic lateral sclerosis	0.00088	0.00976	CcSEcCtD
Clobazam—Malnutrition—Riluzole—amyotrophic lateral sclerosis	0.000875	0.0097	CcSEcCtD
Clobazam—Tension—Riluzole—amyotrophic lateral sclerosis	0.000858	0.00952	CcSEcCtD
Clobazam—Nervousness—Riluzole—amyotrophic lateral sclerosis	0.00085	0.00942	CcSEcCtD
Clobazam—Muscle spasms—Riluzole—amyotrophic lateral sclerosis	0.000841	0.00932	CcSEcCtD
Clobazam—Tremor—Riluzole—amyotrophic lateral sclerosis	0.00082	0.00908	CcSEcCtD
Clobazam—Anaemia—Riluzole—amyotrophic lateral sclerosis	0.000809	0.00896	CcSEcCtD
Clobazam—Agitation—Riluzole—amyotrophic lateral sclerosis	0.000804	0.00891	CcSEcCtD
Clobazam—Leukopenia—Riluzole—amyotrophic lateral sclerosis	0.000783	0.00868	CcSEcCtD
Clobazam—Cough—Riluzole—amyotrophic lateral sclerosis	0.000763	0.00846	CcSEcCtD
Clobazam—Myalgia—Riluzole—amyotrophic lateral sclerosis	0.000745	0.00826	CcSEcCtD
Clobazam—GABRB2—medulla oblongata—amyotrophic lateral sclerosis	0.000742	0.0163	CbGeAlD
Clobazam—GABRG2—medulla oblongata—amyotrophic lateral sclerosis	0.000742	0.0163	CbGeAlD
Clobazam—Anxiety—Riluzole—amyotrophic lateral sclerosis	0.000742	0.00823	CcSEcCtD
Clobazam—Unspecified disorder of skin and subcutaneous tissue—Riluzole—amyotrophic lateral sclerosis	0.00074	0.0082	CcSEcCtD
Clobazam—Dry mouth—Riluzole—amyotrophic lateral sclerosis	0.000728	0.00807	CcSEcCtD
Clobazam—Confusional state—Riluzole—amyotrophic lateral sclerosis	0.00072	0.00798	CcSEcCtD
Clobazam—Infection—Riluzole—amyotrophic lateral sclerosis	0.000709	0.00786	CcSEcCtD
Clobazam—Nervous system disorder—Riluzole—amyotrophic lateral sclerosis	0.0007	0.00776	CcSEcCtD
Clobazam—Thrombocytopenia—Riluzole—amyotrophic lateral sclerosis	0.000699	0.00775	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000695	0.00873	CbGpPWpGaD
Clobazam—Skin disorder—Riluzole—amyotrophic lateral sclerosis	0.000694	0.00769	CcSEcCtD
Clobazam—Hyperhidrosis—Riluzole—amyotrophic lateral sclerosis	0.00069	0.00765	CcSEcCtD
Clobazam—GABRB2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.000681	0.00855	CbGpPWpGaD
Clobazam—Anorexia—Riluzole—amyotrophic lateral sclerosis	0.000681	0.00754	CcSEcCtD
Clobazam—Hypotension—Riluzole—amyotrophic lateral sclerosis	0.000667	0.00739	CcSEcCtD
Clobazam—GABRB2—spinal cord—amyotrophic lateral sclerosis	0.000662	0.0145	CbGeAlD
Clobazam—GABRG2—spinal cord—amyotrophic lateral sclerosis	0.000662	0.0145	CbGeAlD
Clobazam—SLC6A11—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000661	0.0083	CbGpPWpGaD
Clobazam—GABRA1—medulla oblongata—amyotrophic lateral sclerosis	0.000655	0.0144	CbGeAlD
Clobazam—SLC6A11—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000654	0.00821	CbGpPWpGaD
Clobazam—SLC6A11—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000654	0.00821	CbGpPWpGaD
Clobazam—Musculoskeletal discomfort—Riluzole—amyotrophic lateral sclerosis	0.00065	0.00721	CcSEcCtD
Clobazam—Insomnia—Riluzole—amyotrophic lateral sclerosis	0.000646	0.00716	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000642	0.00806	CbGpPWpGaD
Clobazam—Somnolence—Riluzole—amyotrophic lateral sclerosis	0.000635	0.00704	CcSEcCtD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000623	0.00783	CbGpPWpGaD
Clobazam—GABRG2—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.000623	0.00782	CbGpPWpGaD
Clobazam—Decreased appetite—Riluzole—amyotrophic lateral sclerosis	0.000621	0.00688	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00062	0.00778	CbGpPWpGaD
Clobazam—Gastrointestinal disorder—Riluzole—amyotrophic lateral sclerosis	0.000616	0.00683	CcSEcCtD
Clobazam—Fatigue—Riluzole—amyotrophic lateral sclerosis	0.000616	0.00682	CcSEcCtD
Clobazam—Constipation—Riluzole—amyotrophic lateral sclerosis	0.000611	0.00677	CcSEcCtD
Clobazam—SLC6A11—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.00061	0.00766	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000589	0.0074	CbGpPWpGaD
Clobazam—Feeling abnormal—Riluzole—amyotrophic lateral sclerosis	0.000588	0.00652	CcSEcCtD
Clobazam—GABRA1—spinal cord—amyotrophic lateral sclerosis	0.000584	0.0128	CbGeAlD
Clobazam—SLC6A11—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000583	0.00732	CbGpPWpGaD
Clobazam—SLC6A11—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000578	0.00725	CbGpPWpGaD
Clobazam—Urticaria—Riluzole—amyotrophic lateral sclerosis	0.000567	0.00629	CcSEcCtD
Clobazam—SLC6A1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000567	0.00712	CbGpPWpGaD
Clobazam—Body temperature increased—Riluzole—amyotrophic lateral sclerosis	0.000564	0.00626	CcSEcCtD
Clobazam—GABRB2—nervous system—amyotrophic lateral sclerosis	0.000558	0.0122	CbGeAlD
Clobazam—GABRG2—nervous system—amyotrophic lateral sclerosis	0.000558	0.0122	CbGeAlD
Clobazam—GABRA1—GABA receptor activation—KCNJ10—amyotrophic lateral sclerosis	0.000544	0.00684	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000539	0.00676	CbGpPWpGaD
Clobazam—GABRB2—central nervous system—amyotrophic lateral sclerosis	0.000537	0.0118	CbGeAlD
Clobazam—GABRG2—central nervous system—amyotrophic lateral sclerosis	0.000537	0.0118	CbGeAlD
Clobazam—CYP2C19—Melatonin metabolism and effects—ECE1—amyotrophic lateral sclerosis	0.000533	0.00669	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000533	0.00669	CbGpPWpGaD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.00053	0.00665	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000527	0.00662	CbGpPWpGaD
Clobazam—SLC6A1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000527	0.00662	CbGpPWpGaD
Clobazam—GABRB2—cerebellum—amyotrophic lateral sclerosis	0.000525	0.0115	CbGeAlD
Clobazam—GABRG2—cerebellum—amyotrophic lateral sclerosis	0.000525	0.0115	CbGeAlD
Clobazam—Asthenia—Riluzole—amyotrophic lateral sclerosis	0.000512	0.00568	CcSEcCtD
Clobazam—CYP2B6—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000506	0.00636	CbGpPWpGaD
Clobazam—Pruritus—Riluzole—amyotrophic lateral sclerosis	0.000505	0.0056	CcSEcCtD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC1A2—amyotrophic lateral sclerosis	0.000502	0.00631	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000501	0.00629	CbGpPWpGaD
Clobazam—SLC6A11—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000501	0.00629	CbGpPWpGaD
Clobazam—GABRA1—nervous system—amyotrophic lateral sclerosis	0.000492	0.0108	CbGeAlD
Clobazam—SLC6A1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000492	0.00617	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000492	0.00617	CbGpPWpGaD
Clobazam—Diarrhoea—Riluzole—amyotrophic lateral sclerosis	0.000489	0.00541	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000475	0.00596	CbGpPWpGaD
Clobazam—GABRA1—central nervous system—amyotrophic lateral sclerosis	0.000474	0.0104	CbGeAlD
Clobazam—SLC6A11—SLC-mediated transmembrane transport—SLC6A1—amyotrophic lateral sclerosis	0.000472	0.00593	CbGpPWpGaD
Clobazam—Dizziness—Riluzole—amyotrophic lateral sclerosis	0.000472	0.00523	CcSEcCtD
Clobazam—SLC6A1—NRF2 pathway—SQSTM1—amyotrophic lateral sclerosis	0.000466	0.00585	CbGpPWpGaD
Clobazam—GABRA1—cerebellum—amyotrophic lateral sclerosis	0.000463	0.0101	CbGeAlD
Clobazam—Vomiting—Riluzole—amyotrophic lateral sclerosis	0.000454	0.00503	CcSEcCtD
Clobazam—SLC6A11—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000452	0.00567	CbGpPWpGaD
Clobazam—Rash—Riluzole—amyotrophic lateral sclerosis	0.00045	0.00499	CcSEcCtD
Clobazam—Dermatitis—Riluzole—amyotrophic lateral sclerosis	0.00045	0.00499	CcSEcCtD
Clobazam—Headache—Riluzole—amyotrophic lateral sclerosis	0.000447	0.00496	CcSEcCtD
Clobazam—SLC6A11—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000447	0.00561	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000434	0.00545	CbGpPWpGaD
Clobazam—SLC6A1—SLC-mediated transmembrane transport—SLC1A3—amyotrophic lateral sclerosis	0.000427	0.00536	CbGpPWpGaD
Clobazam—GABRB2—brain—amyotrophic lateral sclerosis	0.000426	0.00933	CbGeAlD
Clobazam—GABRG2—brain—amyotrophic lateral sclerosis	0.000426	0.00933	CbGeAlD
Clobazam—Nausea—Riluzole—amyotrophic lateral sclerosis	0.000424	0.0047	CcSEcCtD
Clobazam—SLC6A1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000404	0.00507	CbGpPWpGaD
Clobazam—SLC6A1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000404	0.00507	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000396	0.00497	CbGpPWpGaD
Clobazam—GABRB2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000385	0.00484	CbGpPWpGaD
Clobazam—GABRA1—brain—amyotrophic lateral sclerosis	0.000376	0.00824	CbGeAlD
Clobazam—ABCB1—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.000373	0.00469	CbGpPWpGaD
Clobazam—CYP2C18—FOXA1 transcription factor network—SOD1—amyotrophic lateral sclerosis	0.000365	0.00458	CbGpPWpGaD
Clobazam—SLC6A1—NRF2 pathway—GSTP1—amyotrophic lateral sclerosis	0.000364	0.00457	CbGpPWpGaD
Clobazam—GABRG2—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000352	0.00442	CbGpPWpGaD
Clobazam—ABCB1—embryo—amyotrophic lateral sclerosis	0.000323	0.00708	CbGeAlD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000317	0.00398	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000313	0.00393	CbGpPWpGaD
Clobazam—GABRA1—Ion channel transport—TRPM7—amyotrophic lateral sclerosis	0.000308	0.00387	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—VAPB—amyotrophic lateral sclerosis	0.000304	0.00381	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—TPK1—amyotrophic lateral sclerosis	0.000304	0.00381	CbGpPWpGaD
Clobazam—CYP2B6—nervous system—amyotrophic lateral sclerosis	0.00029	0.00636	CbGeAlD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000289	0.00363	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.000286	0.0036	CbGpPWpGaD
Clobazam—CYP2B6—central nervous system—amyotrophic lateral sclerosis	0.00028	0.00612	CbGeAlD
Clobazam—SLC6A11—Metabolism—VAPA—amyotrophic lateral sclerosis	0.000278	0.00349	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—ECE1—amyotrophic lateral sclerosis	0.00027	0.00339	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000269	0.00338	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000269	0.00338	CbGpPWpGaD
Clobazam—CYP2C18—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000267	0.00336	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000264	0.00332	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—SACM1L—amyotrophic lateral sclerosis	0.000258	0.00324	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	0.000255	0.00321	CbGpPWpGaD
Clobazam—GABRB2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000255	0.0032	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—KCNJ10—amyotrophic lateral sclerosis	0.00025	0.00314	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—FIG4—amyotrophic lateral sclerosis	0.000243	0.00305	CbGpPWpGaD
Clobazam—SLC6A11—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	0.00024	0.00301	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000235	0.00296	CbGpPWpGaD
Clobazam—GABRG2—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000233	0.00293	CbGpPWpGaD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—GRIA2—amyotrophic lateral sclerosis	0.000231	0.0029	CbGpPWpGaD
Clobazam—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—RARA—amyotrophic lateral sclerosis	0.00023	0.00289	CbGpPWpGaD
Clobazam—CYP2B6—brain—amyotrophic lateral sclerosis	0.000222	0.00486	CbGeAlD
Clobazam—SLC6A11—Metabolism—DAO—amyotrophic lateral sclerosis	0.00022	0.00276	CbGpPWpGaD
Clobazam—CYP3A4—nervous system—amyotrophic lateral sclerosis	0.000219	0.0048	CbGeAlD
Clobazam—GABRB2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000217	0.00273	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	0.000217	0.00273	CbGpPWpGaD
Clobazam—SLC6A1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	0.000217	0.00273	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000215	0.0027	CbGpPWpGaD
Clobazam—CYP3A4—central nervous system—amyotrophic lateral sclerosis	0.000211	0.00462	CbGeAlD
Clobazam—GABRB2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.00021	0.00263	CbGpPWpGaD
Clobazam—ABCB1—medulla oblongata—amyotrophic lateral sclerosis	0.000207	0.00452	CbGeAlD
Clobazam—GABRA1—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—NEFL—amyotrophic lateral sclerosis	0.000204	0.00256	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000199	0.00249	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000192	0.00241	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000192	0.00241	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—KCNJ10—amyotrophic lateral sclerosis	0.000188	0.00236	CbGpPWpGaD
Clobazam—ABCB1—spinal cord—amyotrophic lateral sclerosis	0.000184	0.00403	CbGeAlD
Clobazam—GABRB2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.00018	0.00226	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000178	0.00224	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000178	0.00224	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000176	0.0022	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CHAT—amyotrophic lateral sclerosis	0.000174	0.00218	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—SLC1A3—amyotrophic lateral sclerosis	0.000174	0.00218	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—AQP4—amyotrophic lateral sclerosis	0.000174	0.00218	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—GRIA2—amyotrophic lateral sclerosis	0.000174	0.00218	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—SLC1A2—amyotrophic lateral sclerosis	0.000168	0.00211	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PLB1—amyotrophic lateral sclerosis	0.000166	0.00209	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000166	0.00209	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000165	0.00207	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000163	0.00205	CbGpPWpGaD
Clobazam—GABRG2—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000163	0.00205	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000161	0.00202	CbGpPWpGaD
Clobazam—GABRB2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000159	0.002	CbGpPWpGaD
Clobazam—ABCB1—nervous system—amyotrophic lateral sclerosis	0.000155	0.0034	CbGeAlD
Clobazam—SLC6A11—Metabolism—GSR—amyotrophic lateral sclerosis	0.000154	0.00193	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—NEFL—amyotrophic lateral sclerosis	0.000153	0.00193	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000152	0.00191	CbGpPWpGaD
Clobazam—ABCB1—central nervous system—amyotrophic lateral sclerosis	0.000149	0.00327	CbGeAlD
Clobazam—GABRB2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000147	0.00185	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000147	0.00185	CbGpPWpGaD
Clobazam—ABCB1—cerebellum—amyotrophic lateral sclerosis	0.000146	0.0032	CbGeAlD
Clobazam—GABRG2—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000145	0.00183	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—KCNJ10—amyotrophic lateral sclerosis	0.000144	0.00181	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—SLC1A3—amyotrophic lateral sclerosis	0.000143	0.00179	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—CHAT—amyotrophic lateral sclerosis	0.000143	0.00179	CbGpPWpGaD
Clobazam—CYP2C19—Melatonin metabolism and effects—APOE—amyotrophic lateral sclerosis	0.00014	0.00175	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000137	0.00172	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000137	0.00172	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000134	0.00169	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000134	0.00168	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—GRIA2—amyotrophic lateral sclerosis	0.000133	0.00167	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	0.000131	0.00165	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—SLC1A2—amyotrophic lateral sclerosis	0.000129	0.00161	CbGpPWpGaD
Clobazam—GABRA1—Transmission across Chemical Synapses—SLC6A1—amyotrophic lateral sclerosis	0.000127	0.0016	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—CHAT—amyotrophic lateral sclerosis	0.000126	0.00158	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000125	0.00157	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000125	0.00157	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000123	0.00154	CbGpPWpGaD
Clobazam—GABRB2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000122	0.00153	CbGpPWpGaD
Clobazam—CYP2C18—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	0.00012	0.0015	CbGpPWpGaD
Clobazam—ABCB1—brain—amyotrophic lateral sclerosis	0.000119	0.0026	CbGeAlD
Clobazam—CYP2C18—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	0.000118	0.00148	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—NEFL—amyotrophic lateral sclerosis	0.000118	0.00148	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP12—amyotrophic lateral sclerosis	0.000115	0.00145	CbGpPWpGaD
Clobazam—GABRG2—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	0.000111	0.0014	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—PLA2G4A—amyotrophic lateral sclerosis	0.00011	0.00138	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—SLC1A3—amyotrophic lateral sclerosis	0.000109	0.00137	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—CHAT—amyotrophic lateral sclerosis	0.000109	0.00137	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	0.000107	0.00135	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	9.93e-05	0.00125	CbGpPWpGaD
Clobazam—GABRA1—Neuronal System—SLC6A1—amyotrophic lateral sclerosis	9.74e-05	0.00122	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—RARA—amyotrophic lateral sclerosis	9.39e-05	0.00118	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CASP9—amyotrophic lateral sclerosis	9.23e-05	0.00116	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—TPK1—amyotrophic lateral sclerosis	9.17e-05	0.00115	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—VAPB—amyotrophic lateral sclerosis	9.17e-05	0.00115	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—BDNF—amyotrophic lateral sclerosis	9e-05	0.00113	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	8.64e-05	0.00109	CbGpPWpGaD
Clobazam—Clomipramine—GSTP1—amyotrophic lateral sclerosis	8.48e-05	0.446	CrCbGaD
Clobazam—CYP2C18—Metabolism—VAPA—amyotrophic lateral sclerosis	8.38e-05	0.00105	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	7.91e-05	0.000992	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—SACM1L—amyotrophic lateral sclerosis	7.79e-05	0.000978	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—VAPB—amyotrophic lateral sclerosis	7.65e-05	0.00096	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CD40LG—amyotrophic lateral sclerosis	7.43e-05	0.000932	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	7.35e-05	0.000923	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	7.35e-05	0.000923	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—FIG4—amyotrophic lateral sclerosis	7.33e-05	0.00092	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—VAPA—amyotrophic lateral sclerosis	6.99e-05	0.000878	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	6.91e-05	0.000867	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—GSTP1—amyotrophic lateral sclerosis	6.78e-05	0.000851	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	6.72e-05	0.000844	CbGpPWpGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	6.72e-05	0.000844	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—DAO—amyotrophic lateral sclerosis	6.63e-05	0.000832	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—C3—amyotrophic lateral sclerosis	6.56e-05	0.000824	CbGpPWpGaD
Clobazam—GABRB2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	6.55e-05	0.000822	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—SACM1L—amyotrophic lateral sclerosis	6.5e-05	0.000816	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—MAPT—amyotrophic lateral sclerosis	6.46e-05	0.000811	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CST3—amyotrophic lateral sclerosis	6.26e-05	0.000786	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.23e-05	0.000782	CbGpPWpGaD
Clobazam—CYP2C19—Arachidonic acid metabolism—PTGS2—amyotrophic lateral sclerosis	6.19e-05	0.000777	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—FIG4—amyotrophic lateral sclerosis	6.11e-05	0.000767	CbGpPWpGaD
Clobazam—Antipyrine—PTGS2—amyotrophic lateral sclerosis	6.08e-05	0.32	CrCbGaD
Clobazam—GABRG2—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.99e-05	0.000752	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—GSR—amyotrophic lateral sclerosis	5.97e-05	0.00075	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—amyotrophic lateral sclerosis	5.9e-05	0.00074	CbGpPWpGaD
Clobazam—CYP2B6—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	5.88e-05	0.000738	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	5.88e-05	0.000738	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	5.88e-05	0.000738	CbGpPWpGaD
Clobazam—CYP2B6—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	5.8e-05	0.000728	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—TRPM7—amyotrophic lateral sclerosis	5.38e-05	0.000675	CbGpPWpGaD
Clobazam—GABRA1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	5.24e-05	0.000657	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—APOE—amyotrophic lateral sclerosis	5.13e-05	0.000644	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PLB1—amyotrophic lateral sclerosis	5.02e-05	0.00063	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GSR—amyotrophic lateral sclerosis	4.63e-05	0.000582	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP9—amyotrophic lateral sclerosis	4.55e-05	0.000572	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—VAPB—amyotrophic lateral sclerosis	4.51e-05	0.000566	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—TPK1—amyotrophic lateral sclerosis	4.51e-05	0.000566	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—CASP3—amyotrophic lateral sclerosis	4.5e-05	0.000565	CbGpPWpGaD
Clobazam—Phenylbutazone—PTGS2—amyotrophic lateral sclerosis	4.46e-05	0.234	CrCbGaD
Clobazam—CYP2C19—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	4.44e-05	0.000558	CbGpPWpGaD
Clobazam—CYP2C19—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	4.38e-05	0.00055	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PLB1—amyotrophic lateral sclerosis	4.19e-05	0.000526	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—VAPA—amyotrophic lateral sclerosis	4.12e-05	0.000517	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—CASP3—amyotrophic lateral sclerosis	3.89e-05	0.000488	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—amyotrophic lateral sclerosis	3.84e-05	0.000482	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—SACM1L—amyotrophic lateral sclerosis	3.83e-05	0.000481	CbGpPWpGaD
Clobazam—GABRA1—SIDS Susceptibility Pathways—VEGFA—amyotrophic lateral sclerosis	3.82e-05	0.000479	CbGpPWpGaD
Clobazam—ABCB1—HIF-1-alpha transcription factor network—VEGFA—amyotrophic lateral sclerosis	3.81e-05	0.000478	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—CHAT—amyotrophic lateral sclerosis	3.81e-05	0.000478	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PLA2G4A—amyotrophic lateral sclerosis	3.67e-05	0.00046	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—FIG4—amyotrophic lateral sclerosis	3.6e-05	0.000452	CbGpPWpGaD
Clobazam—SLC6A11—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.51e-05	0.000441	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC1A2—amyotrophic lateral sclerosis	3.47e-05	0.000435	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—TPK1—amyotrophic lateral sclerosis	3.41e-05	0.000428	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—VAPB—amyotrophic lateral sclerosis	3.41e-05	0.000428	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—VAPB—amyotrophic lateral sclerosis	3.32e-05	0.000417	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—TPK1—amyotrophic lateral sclerosis	3.32e-05	0.000417	CbGpPWpGaD
Clobazam—ABCB1—Allograft Rejection—VEGFA—amyotrophic lateral sclerosis	3.3e-05	0.000414	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—DAO—amyotrophic lateral sclerosis	3.26e-05	0.000409	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—CHAT—amyotrophic lateral sclerosis	3.18e-05	0.000399	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—VAPA—amyotrophic lateral sclerosis	3.11e-05	0.000391	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—VAPA—amyotrophic lateral sclerosis	3.04e-05	0.000382	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—AQP4—amyotrophic lateral sclerosis	2.95e-05	0.00037	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC1A3—amyotrophic lateral sclerosis	2.95e-05	0.00037	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.9e-05	0.000363	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—SACM1L—amyotrophic lateral sclerosis	2.83e-05	0.000355	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—FIG4—amyotrophic lateral sclerosis	2.72e-05	0.000342	CbGpPWpGaD
Clobazam—CYP3A4—Biological oxidations—GSTP1—amyotrophic lateral sclerosis	2.67e-05	0.000335	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—FIG4—amyotrophic lateral sclerosis	2.66e-05	0.000334	CbGpPWpGaD
Clobazam—CYP3A4—Metapathway biotransformation—GSTP1—amyotrophic lateral sclerosis	2.64e-05	0.000331	CbGpPWpGaD
Clobazam—ABCB1—Transmembrane transport of small molecules—SLC6A1—amyotrophic lateral sclerosis	2.63e-05	0.00033	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—amyotrophic lateral sclerosis	2.49e-05	0.000313	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PLB1—amyotrophic lateral sclerosis	2.47e-05	0.00031	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—DAO—amyotrophic lateral sclerosis	2.46e-05	0.000309	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—DAO—amyotrophic lateral sclerosis	2.4e-05	0.000302	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GSR—amyotrophic lateral sclerosis	2.28e-05	0.000286	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—amyotrophic lateral sclerosis	2.07e-05	0.000259	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—VAPB—amyotrophic lateral sclerosis	2.05e-05	0.000257	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—TPK1—amyotrophic lateral sclerosis	2.05e-05	0.000257	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—GSTP1—amyotrophic lateral sclerosis	2.05e-05	0.000257	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—amyotrophic lateral sclerosis	1.92e-05	0.000241	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	1.88e-05	0.000236	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—VAPA—amyotrophic lateral sclerosis	1.87e-05	0.000235	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—CHAT—amyotrophic lateral sclerosis	1.87e-05	0.000235	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PLB1—amyotrophic lateral sclerosis	1.87e-05	0.000234	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PLB1—amyotrophic lateral sclerosis	1.82e-05	0.000229	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—SACM1L—amyotrophic lateral sclerosis	1.74e-05	0.000219	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GSR—amyotrophic lateral sclerosis	1.72e-05	0.000216	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GSR—amyotrophic lateral sclerosis	1.68e-05	0.000211	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—FIG4—amyotrophic lateral sclerosis	1.64e-05	0.000206	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—amyotrophic lateral sclerosis	1.63e-05	0.000204	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PLA2G4A—amyotrophic lateral sclerosis	1.57e-05	0.000197	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—APOE—amyotrophic lateral sclerosis	1.55e-05	0.000194	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—DAO—amyotrophic lateral sclerosis	1.48e-05	0.000186	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—CHAT—amyotrophic lateral sclerosis	1.41e-05	0.000178	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—CHAT—amyotrophic lateral sclerosis	1.38e-05	0.000173	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—APOE—amyotrophic lateral sclerosis	1.29e-05	0.000162	CbGpPWpGaD
Clobazam—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—amyotrophic lateral sclerosis	1.23e-05	0.000154	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PLB1—amyotrophic lateral sclerosis	1.12e-05	0.000141	CbGpPWpGaD
Clobazam—CYP2C18—Metabolism—PTGS2—amyotrophic lateral sclerosis	1.06e-05	0.000133	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GSR—amyotrophic lateral sclerosis	1.04e-05	0.00013	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—GSTP1—amyotrophic lateral sclerosis	1.01e-05	0.000126	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	9.24e-06	0.000116	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—amyotrophic lateral sclerosis	8.84e-06	0.000111	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—CHAT—amyotrophic lateral sclerosis	8.5e-06	0.000107	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—APOE—amyotrophic lateral sclerosis	7.6e-06	9.55e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.6e-06	9.54e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—GSTP1—amyotrophic lateral sclerosis	7.42e-06	9.31e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.98e-06	8.77e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	6.82e-06	8.56e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—APOE—amyotrophic lateral sclerosis	5.75e-06	7.21e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—APOE—amyotrophic lateral sclerosis	5.61e-06	7.04e-05	CbGpPWpGaD
Clobazam—CYP2B6—Metabolism—PTGS2—amyotrophic lateral sclerosis	5.21e-06	6.54e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—GSTP1—amyotrophic lateral sclerosis	4.57e-06	5.74e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PLA2G4A—amyotrophic lateral sclerosis	4.2e-06	5.27e-05	CbGpPWpGaD
Clobazam—CYP2C19—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.94e-06	4.94e-05	CbGpPWpGaD
Clobazam—ABCB1—Metabolism—PTGS2—amyotrophic lateral sclerosis	3.84e-06	4.82e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—APOE—amyotrophic lateral sclerosis	3.46e-06	4.34e-05	CbGpPWpGaD
Clobazam—CYP3A4—Metabolism—PTGS2—amyotrophic lateral sclerosis	2.37e-06	2.97e-05	CbGpPWpGaD
